Preprint · CC-BY
via bioRxiv
Integrative single-cell analysis of neural stem/progenitor cells reveals epigenetically dysregulated interferon response in progressive multiple sclerosis
Park, B., Nicaise, A., Tsitsipatis, D., Pirvan, L., Prasad, P., Larraz Lopez De Novales, M., Whitten, J., Culig, L., Llewellyn, J., Ionescu, R.-B., Willis, C., Krzak, G., Fan, J., De, S., Suarez Cubero, M.
biorxiv · 2024
Epigenetic alterations
Cellular senescence
Stem-cell exhaustion
Chronic inflammation
Partial reprogramming (OSK)
Cell culture / in vitro
In vitro
Abstract
Progressive multiple sclerosis (PMS) is characterized by a primary smouldering pathological disease process associated with a superimposed inflammatory activity. Cellular and molecular processes sustaining the pathobiology of PMS remain to be identified.
We previously discovered senescence(definition) signatures in neural stem/progenitor cells (NSCs) from people with PMS. Applying direct reprogramming to generate directly induced NSCs (iNSCs) from somatic fibroblasts, we retain epigenetic information and observe hypomethylation of genes associated with lipid metabolic processes and IFN signalling only in PMS lines. Single-cell/nucleus transcriptomic and epigenetic profiling reveal an inflammatory, senescent-like, IFN-responsive radial glia (RG)-like cell subcluster mainly in PMS iNSCs that is driven by IFN-associated transcription factors. Lastly, we identify a population of senescent, IFN-responsive, disease-associated RG-like cells (DARGs) in the PMS brain that share pseudotime trajectories with iNSCs in vitro.
We describe the existence of a non-neurogenic, dysfunctional DARG population that has the potential to fuel smouldering inflammation in PMS.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- bioRxiv
- DOI
- 10.1101/2024.02.09.579648
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
B., P., A., N., D., T., L., P., P., P., M., L.L.D.N., J., W., L., C., J., L., R.-B., I., C., W., G., K., J., F., S., D., M., S.C., A., S., L., P., t., L., F., E., & M., G. (2024). Integrative single-cell analysis of neural stem/progenitor cells reveals epigenetically dysregulated interferon response in progressive multiple sclerosis. <em>biorxiv</em>. https://doi.org/10.1101/2024.02.09.579648
Vancouver
B. P, A. N, D. T, L. P, P. P, M. LLDN, et al. Integrative single-cell analysis of neural stem/progenitor cells reveals epigenetically dysregulated interferon response in progressive multiple sclerosis. biorxiv. 2024. doi:10.1101/2024.02.09.579648.
BibTeX
@unpublished{park2024Integr,
title = {Integrative single-cell analysis of neural stem/progenitor cells reveals epigenetically dysregulated interferon response in progressive multiple sclerosis},
author = {Park, B. and Nicaise, A. and Tsitsipatis, D. and Pirvan, L. and Prasad, P. and Larraz Lopez De Novales, M. and Whitten, J. and Culig, L. and Llewellyn, J. and Ionescu, R.-B. and Willis, C. and Krzak, G. and Fan, J. and De, S. and Suarez Cubero, M. and Spathopoulou, A. and Peruzzotti-Jametti, L. and Leonardi, t. and Edenhofer, F. and Gorospe, M. and Mohorianu, I. and Pluchino, S. and Beerman, I.},
journal = {biorxiv},
year = {2024},
doi = {10.1101/2024.02.09.579648},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging 2022
Open access · CC-BY
Increased DNA methylation, cellular senescence and premature epigenetic aging in guinea pigs and humans with tuberculosis
Nutrients 2026
Open access · OA
Early Biomarkers, Risk Factors, and Functional Indicators of Healthy Longevity and Their Relationship with Diet.
BMC Geriatrics 2002
Open access · OA
Frailty, fitness and late-life mortality in relation to chronological and biological age
Frontiers in Pharmacology 2017
Open access · CC-BY
Tetrandrine, an Activator of Autophagy, Induces Autophagic Cell Death via PKC-α Inhibition and mTOR-Dependent Mechanisms
Nature Communications 2018
Open access · CC-BY
A transcriptomic atlas of aged human microglia
Pharmaceuticals 2019
Open access · CC-BY